Understanding blood flow changes to prevent tissue loss after spinal cord injury
Hemodynamic basis for secondary cervical grey matter tissue loss after spinal cord injury
This study is looking at how changes in blood flow after a spinal cord injury can cause more damage, and it's for people with cervical spinal cord injuries to help find ways to improve their recovery and protect their spinal cord.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11058448 on NIH RePORTER |
What this research studies
This research investigates how blood flow changes in the spinal cord after an injury can lead to further tissue loss, particularly in patients with cervical spinal cord injuries. Using a novel imaging technique, researchers will monitor blood flow in real-time to identify critical parameters that could help protect the spinal cord from secondary damage. The study aims to develop therapeutic strategies that could improve recovery outcomes for patients suffering from paralysis and respiratory dysfunction due to spinal cord injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced a cervical spinal cord injury and are facing challenges such as paralysis or respiratory issues.
Not a fit: Patients with spinal cord injuries located in areas other than the cervical spine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery and quality of life for patients with cervical spinal cord injuries.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques to monitor blood flow in other contexts, suggesting potential for success in this novel approach.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Khaing, Zin Z — University of Washington
- Study coordinator: Khaing, Zin Z
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.